Robbins Geller investigates GPGI after Q1 results miss
Robbins Geller Rudman & Dowd LLP has launched an investigation into GPGI, Inc. regarding potential violations of federal securities laws. The probe follows a 26% drop in GPGI's stock price after the company reported Q1 2026 results showing a 5.2% decline in Husky segment sales and a 40.2% drop in EBITDA. The firm is inviting affected investors to contact them.

*this image is generated using AI for illustrative purposes only.
Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving GPGI, Inc. (NYSE: GPGI) following a significant stock decline. The investigation centers on whether the company or its executives misled investors regarding its financial condition and business prospects. On May 7, 2026, GPGI reported its first quarter 2026 financial results, revealing that its Husky segment's Pro Forma Adjusted Net Sales were $290.8 million, down 5.2% year-over-year, and its Pro Forma Adjusted EBITDA fell to $38 million, down 40.2% year-over-year. Following this disclosure, the price of GPGI stock fell nearly 26%.
GPGI, together with its subsidiaries, provides sustainable injection molding solutions worldwide. The law firm's inquiry aims to determine if statements made by the company were inaccurate or if material information was withheld. Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder rights litigation, having recovered $916 million for investors in 2025.
Investors who suffered losses in GPGI are encouraged to contact the firm. Shareholders can provide information or learn more about the investigation by visiting the firm's dedicated case page. There is no cost or obligation to participate.
Key Details
| Entity | Role | Contact Information |
|---|---|---|
| Robbins Geller Rudman & Dowd LLP | Investigating Firm | 800-851-7783, info@rgrdlaw.com |
| GPGI, Inc. | Company Under Investigation | NYSE: GPGI |
Attorneys Ken Dolitsky and Michael Albert are leading the investigation for Robbins Geller. The firm is headquartered at 655 W. Broadway, Suite 1900, San Diego, CA 92101. Past results do not guarantee a similar outcome in this matter.
What specific internal or external factors contributed most significantly to the 40.2% decline in Husky segment Pro Forma Adjusted EBITDA?
How does GPGI plan to address the operational inefficiencies revealed in the Q1 2026 report to restore investor confidence?
Is the anticipated securities litigation likely to trigger management changes or a strategic pivot within GPGI’s business model?
























